Discovery Capital Management, LLC Pfizer Inc Transaction History

Discovery Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $30.6 Million - $35.8 Million	954,350 New	954,350 $31.7 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $15.8 Million - $19.5 Million	-344,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $10.4 Million - $15.4 Million	-251,600 Reduced 42.21%	344,500 $20.3 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $10.4 Million - $13.3 Million	263,900 Added 79.44%	596,100 $25.6 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $6.36 Million - $7.2 Million	177,000 Added 114.05%	332,200 $13 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $5.2 Million - $5.86 Million	155,200 New	155,200 $5.62 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $12.2 Million - $15.5 Million	-364,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $11.6 Million - $13.6 Million	364,500 New	364,500 $13.4 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Discovery Capital Management, LLC , based on Form 13F filings with the SEC.

Stay updated on Discovery Capital Management, LLC with notifications on news.